# Unified Risk Analysis

[![ISO 14971](https://img.shields.io/badge/ISO%2014971-Compliant-blue?style=flat-square)](https://www.iso.org/standard/72704.html)
[![FDA](https://img.shields.io/badge/FDA-21%20CFR%20820-blue?style=flat-square)](https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=820)
[![CDSCO](https://img.shields.io/badge/CDSCO-MDR%202017-orange?style=flat-square)](https://cdsco.gov.in/opencms/opencms/en/Medical-Device-Diagnostics/Medical-Device-Diagnostics/)
[![BIS](https://img.shields.io/badge/BIS-IS%2023485-green?style=flat-square)](https://www.bis.gov.in/)
[![Make in India](https://img.shields.io/badge/Make%20in%20India-Initiative-orange?style=flat-square)](https://www.makeinindia.com/)

## üìã Document Information

| **Document Information** |                                                |
|--------------------------|------------------------------------------------|
| **Document ID**          | RM-ANALYSIS-UNIFIED-001                        |
| **Version**              | 2.0.0                                          |
| **Date Created**         | April 17, 2025                                 |
| **Last Updated**         | April 17, 2025                                 |
| **Author**               | Chimera Risk Management Team                   |
| **Reviewers**            | CEO, CTO, Clinical Director, Quality Director, Regulatory Affairs Director |
| **Status**               | Approved                                       |

## üìù Document Revision History

| Version | Date | Author | Description of Changes |
|---------|------|--------|------------------------|
| 1.0.0 | April 17, 2025 | Risk Management Team | Initial version |
| 2.0.0 | April 17, 2025 | Risk Management Team | Enhanced version with improved aesthetics and detailed content |

## üéØ Purpose and Scope

### 1.1 Purpose

This Unified Risk Analysis document provides a comprehensive identification, analysis, and evaluation of risks associated with the Chimera neural interface system. It integrates risk analysis approaches from both US FDA and Indian CDSCO regulatory frameworks while adhering to international standards, particularly ISO 14971:2019.

### 1.2 Scope

This document applies to:

- All components of the Chimera neural interface system
- All phases of the product lifecycle from concept to post-market
- All geographical markets, with specific focus on US and Indian requirements
- All use environments, including clinical settings and Indian home environments
- All risk types including technical, clinical, usability, cybersecurity, and India-specific infrastructure risks

## üåê Regulatory Framework

### 2.1 International Standards

- **ISO 14971:2019**: Medical devices ‚Äî Application of risk management to medical devices
- **ISO/TR 24971:2020**: Medical devices ‚Äî Guidance on the application of ISO 14971
- **IEC 62304:2015**: Medical device software ‚Äî Software life cycle processes
- **IEC 62366-1:2015**: Medical devices ‚Äî Application of usability engineering to medical devices
- **ISO 13485:2016**: Medical devices ‚Äî Quality management systems ‚Äî Requirements for regulatory purposes
- **ISO 27001:2022**: Information security management systems ‚Äî Requirements

### 2.2 US FDA Requirements

- **21 CFR Part 820**: Quality System Regulation
- **21 CFR Part 803**: Medical Device Reporting
- **21 CFR Part 806**: Medical Devices; Reports of Corrections and Removals
- **FDA Guidance**: Factors to Consider Regarding Benefit-Risk in Medical Device Product Availability, Compliance, and Enforcement Decisions
- **FDA Guidance**: Applying Human Factors and Usability Engineering to Medical Devices
- **FDA Guidance**: Content of Premarket Submissions for Management of Cybersecurity in Medical Devices
- **FDA Guidance**: Software as a Medical Device (SaMD): Clinical Evaluation

### 2.3 Indian CDSCO Requirements

- **Medical Device Rules, 2017** (as amended)
- **CDSCO Guidelines for Software as Medical Device (SaMD)**
- **Digital Personal Data Protection Act, 2023**
- **Bureau of Indian Standards (BIS) IS 23485**: Medical devices ‚Äî Quality management systems ‚Äî Requirements for regulatory purposes
- **CERT-In Guidelines** for cybersecurity
- **Make in India Initiative** requirements for medical devices

## üîç Risk Analysis Methodology

### 3.1 Risk Analysis Process

The risk analysis process follows the ISO 14971:2019 framework with enhancements to address FDA and CDSCO requirements:

![Risk Analysis Process](https://mermaid.ink/img/pako:eNp1kk9PwzAMxb9KlBMIbRLtH8EBiQNCaKBx4MIl8lK3jdYkVeJuGqPfnbRFMG3jEsXP7_fsOBfGrSQo4AV5S4bxoQ33SFZEcULy0VkkT9aRVhFd0DokZC9WRZSEvEZFZAypCFdklXekI1zEeZzHWZzH_2Ln-6gjXMZ5nMd5nMf5v9hFhFdxHudxHudxHucxdn6OOsJ1nMd5nMd5nMd5jJ3foo7wLs7jPM7jPM7jPMbOH1FH-BjncR7ncR7ncR5j50_UEX7FeZzHeZzHeZzH2HkXdYQ_cR7ncR7ncR7nMXb-jTrCY5zHeZzHeZzHeYyd06gjPMV5nMd5nMd5nMfYOYvwFOdxHudxHudxHmPnPMJTnMd5nMd5nMd5jJ2LCE9xHudxHudxHucxdi4jPMd5nMd5nMd5nMfYuYrwHOdxHudxHudxHmPnOsJLnMd5nMd5nMd5jJ2bCC9xHudxHudxHucxdm4jvMR5nMd5nMd5nMfYuYvwEudxHudxHudxHmPnPsJrnMd5nMd5nMd5jJ3HCK9xHudxHudxHucxdp4ivMV5nMd5nMd5nMfYeY7wFudxHudxHudxHmPnJcJbnMd5nMd5nMd5jJ3XCG9xHudxHudxHucxdt4ivMd5nMd5nMd5nMfYeY_wHudxHudxHudxHmPnI8J7nMd5nMd5nMd5jJ2vCB9xHudxHudxHucxdr4jfMR5nMd5nMd5nMfY-YnwEedxHudxHudxHmPnvwgfcR7ncR7ncR7nMXb-B8b18Ck?type=png)

1. **Hazard Identification**:
   - Systematic identification of potential sources of harm
   - Consideration of all reasonably foreseeable circumstances
   - Inclusion of both general and market-specific hazards

2. **Risk Estimation**:
   - Determination of severity of potential harm
   - Estimation of probability of occurrence
   - Calculation of risk level

3. **Risk Evaluation**:
   - Comparison of estimated risks against acceptance criteria
   - Determination of risk acceptability
   - Prioritization of risks for control measures

### 3.2 Risk Analysis Methods

The following methods were used for risk analysis:

1. **Preliminary Hazard Analysis (PHA)**
   - Systematic identification of hazards early in the design process
   - Consideration of intended use and reasonably foreseeable misuse
   - Initial risk estimation and evaluation

2. **Failure Mode and Effects Analysis (FMEA)**
   - Systematic analysis of potential failure modes
   - Determination of effects of failures
   - Calculation of Risk Priority Numbers (RPNs)

3. **Fault Tree Analysis (FTA)**
   - Top-down analysis of potential system failures
   - Identification of combinations of events leading to hazards
   - Calculation of failure probabilities

4. **Use Error Analysis (UEA)**
   - Identification of potential use errors
   - Analysis of causes and effects of use errors
   - Consideration of user interface design factors

5. **Software Hazard Analysis (SHA)**
   - Identification of software-related hazards
   - Analysis of software failure modes
   - Consideration of software architecture and design

6. **Cybersecurity Threat Modeling**
   - Identification of potential cybersecurity threats
   - Analysis of attack vectors and vulnerabilities
   - Assessment of impact on safety and performance

7. **Environmental Risk Analysis**
   - Identification of environmental factors affecting safety
   - Analysis of environmental stresses on the device
   - Consideration of environmental variations across markets

8. **Infrastructure Risk Analysis**
   - Identification of infrastructure-related hazards
   - Analysis of infrastructure variations across markets
   - Consideration of infrastructure limitations and challenges

9. **Home Use Risk Analysis**
   - Identification of home use-specific hazards
   - Analysis of unsupervised use scenarios
   - Consideration of home environment variations

### 3.3 Risk Estimation Parameters

#### 3.3.1 Severity Categories

| Level | Category | Definition | Examples |
|-------|----------|------------|----------|
| 5 | Catastrophic | Results in patient death | Fatal electric shock, fatal brain hemorrhage |
| 4 | Critical | Results in permanent impairment or life-threatening injury | Permanent neurological damage, severe brain injury |
| 3 | Serious | Results in injury or impairment requiring medical intervention | Seizure, infection requiring antibiotics, burns |
| 2 | Minor | Results in temporary injury or impairment not requiring medical intervention | Skin irritation, headache, temporary discomfort |
| 1 | Negligible | Inconvenience or temporary discomfort | Mild discomfort, delayed therapy, cosmetic issue |

#### 3.3.2 Probability Categories

| Level | Category | Definition | Quantitative Range |
|-------|----------|------------|-------------------|
| 5 | Frequent | Likely to occur often | > 10^-3 |
| 4 | Probable | Likely to occur several times | 10^-3 to 10^-4 |
| 3 | Occasional | Likely to occur sometime | 10^-4 to 10^-5 |
| 2 | Remote | Unlikely but possible to occur | 10^-5 to 10^-6 |
| 1 | Improbable | So unlikely that it can be assumed occurrence may not be experienced | < 10^-6 |

#### 3.3.3 Risk Level Matrix

| Severity ‚Üí <br> Probability ‚Üì | 1-Negligible | 2-Minor | 3-Serious | 4-Critical | 5-Catastrophic |
|-------------------------------|--------------|---------|-----------|------------|----------------|
| 5-Frequent | Medium | High | Very High | Very High | Very High |
| 4-Probable | Low | Medium | High | Very High | Very High |
| 3-Occasional | Low | Low | Medium | High | Very High |
| 2-Remote | Low | Low | Low | Medium | High |
| 1-Improbable | Low | Low | Low | Low | Medium |

### 3.4 Risk Acceptability Criteria

| Risk Level | Acceptability | Required Action |
|------------|---------------|----------------|
| Very High | Unacceptable | Must implement risk control measures to reduce risk |
| High | Unacceptable | Must implement risk control measures to reduce risk |
| Medium | ALARP | Implement risk control measures where practicable |
| Low | Acceptable | No further risk reduction required |

*ALARP = As Low As Reasonably Practicable*

## üìä System Description

### 4.1 Device Overview

The Chimera neural interface system is a Brain-Computer Interface (BCI) controlled exoskeleton designed to restore mobility for individuals with mobility impairments. The system consists of:

1. **Neural Interface Subsystem**:
   - Non-invasive EEG headset with dry electrodes
   - Signal amplification and filtering circuitry
   - Signal processing unit
   - Wireless communication module

2. **Exoskeleton Subsystem**:
   - Lower limb exoskeleton frame
   - Electric actuators at hip, knee, and ankle joints
   - Position and force sensors
   - Battery power system
   - Control electronics

3. **Software Subsystem**:
   - Signal processing algorithms
   - Machine learning classification system
   - Movement control algorithms
   - User interface software
   - Diagnostic and monitoring software
   - Wireless communication software

4. **Accessories**:
   - Battery charger
   - Calibration tools
   - Cleaning supplies
   - Storage case
   - User manuals and training materials

### 4.2 Intended Use

The Chimera neural interface system is intended to be used by individuals with mobility impairments to restore walking function. The device is intended for use by adults (18 years and older) with:

- Spinal cord injury (T4 level or below)
- Stroke with lower limb paralysis
- Multiple sclerosis with lower limb weakness
- Other neurological conditions causing lower limb mobility impairment

### 4.3 Intended Use Environment

The device is intended for use in:

- Clinical settings under professional supervision during initial training
- Home environments without professional supervision after training
- Indoor and controlled outdoor environments
- Various geographical locations including the United States and India

### 4.4 User Profile

The intended users of the device include:

- **Primary Users**: Individuals with mobility impairments
- **Secondary Users**: Healthcare professionals for setup and training
- **Tertiary Users**: Caregivers and family members for assistance

The primary users are expected to have:

- Completed a comprehensive training program
- Demonstrated competency in device operation
- Cognitive ability to understand and follow instructions
- Upper limb function sufficient to operate controls
- Body weight and dimensions within specified ranges

## üîç Identified Hazards and Risks

### 5.1 BCI Subsystem Hazards and Risks

<table>
<tr>
<th>ID</th>
<th>Hazard</th>
<th>Cause</th>
<th>Harm</th>
<th>Severity</th>
<th>Probability</th>
<th>Risk Level</th>
</tr>
<tr>
<td>BCI-01</td>
<td>Electrode displacement</td>
<td>Improper placement, movement during use</td>
<td>Signal loss, inaccurate control</td>
<td>3</td>
<td>4</td>
<td>High</td>
</tr>
<tr>
<td>BCI-02</td>
<td>Electrode degradation</td>
<td>Material wear, chemical reactions</td>
<td>Signal quality reduction, skin irritation</td>
<td>2</td>
<td>3</td>
<td>Low</td>
</tr>
<tr>
<td>BCI-03</td>
<td>Signal interference</td>
<td>External electromagnetic sources</td>
<td>Erratic device behavior, potential injury</td>
<td>4</td>
<td>3</td>
<td>High</td>
</tr>
<tr>
<td>BCI-04</td>
<td>Signal amplification error</td>
<td>Component failure, calibration error</td>
<td>Weak or excessive signal, control issues</td>
<td>3</td>
<td>2</td>
<td>Low</td>
</tr>
<tr>
<td>BCI-05</td>
<td>Signal processing delay</td>
<td>Algorithm inefficiency, processor limitations</td>
<td>Delayed response, potential fall</td>
<td>3</td>
<td>3</td>
<td>Medium</td>
</tr>
<tr>
<td>BCI-06</td>
<td>Excessive contact pressure</td>
<td>Improper fitting, design flaw</td>
<td>Skin irritation, discomfort, pressure sores</td>
<td>3</td>
<td>3</td>
<td>Medium</td>
</tr>
<tr>
<td>BCI-07</td>
<td>Allergic reaction</td>
<td>Material incompatibility</td>
<td>Skin irritation, inflammation</td>
<td>3</td>
<td>2</td>
<td>Low</td>
</tr>
<tr>
<td>BCI-08</td>
<td>Electrical leakage</td>
<td>Insulation failure, moisture ingress</td>
<td>Electrical shock, tissue damage</td>
<td>4</td>
<td>2</td>
<td>Medium</td>
</tr>
<tr>
<td>BCI-09</td>
<td>Battery failure</td>
<td>Manufacturing defect, charging issues</td>
<td>Device shutdown, potential fall</td>
<td>3</td>
<td>2</td>
<td>Low</td>
</tr>
<tr>
<td>BCI-10</td>
<td>Overheating</td>
<td>Component failure, excessive use</td>
<td>Burns, component damage</td>
<td>3</td>
<td>2</td>
<td>Low</td>
</tr>
<tr>
<td>BCI-11</td>
<td>Signal misclassification</td>
<td>Algorithm error, training inadequacy</td>
<td>Unintended movement, potential injury</td>
<td>4</td>
<td>4</td>
<td>Very High</td>
</tr>
<tr>
<td>BCI-12</td>
<td>Calibration drift</td>
<td>Time, temperature, component aging</td>
<td>Reduced accuracy, potential fall</td>
<td>3</td>
<td>3</td>
<td>Medium</td>
</tr>
<tr>
<td>BCI-13</td>
<td>Wireless communication failure</td>
<td>Interference, component failure</td>
<td>Loss of control, potential injury</td>
<td>4</td>
<td>3</td>
<td>High</td>
</tr>
<tr>
<td>BCI-14</td>
<td>Inadequate signal quality</td>
<td>Hair interference, poor contact</td>
<td>Unreliable control, potential fall</td>
<td>3</td>
<td>4</td>
<td>High</td>
</tr>
<tr>
<td>BCI-15</td>
<td>Headset mechanical failure</td>
<td>Material fatigue, impact damage</td>
<td>Device malfunction, potential injury</td>
<td>3</td>
<td>2</td>
<td>Low</td>
</tr>
</table>

### 5.2 Exoskeleton Subsystem Hazards and Risks

<table>
<tr>
<th>ID</th>
<th>Hazard</th>
<th>Cause</th>
<th>Harm</th>
<th>Severity</th>
<th>Probability</th>
<th>Risk Level</th>
</tr>
<tr>
<td>EXO-01</td>
<td>Joint misalignment</td>
<td>Improper fitting, adjustment error</td>
<td>Joint stress, discomfort, potential injury</td>
<td>3</td>
<td>3</td>
<td>Medium</td>
</tr>
<tr>
<td>EXO-02</td>
<td>Mechanical failure</td>
<td>Material fatigue, manufacturing defect</td>
<td>Loss of support, potential fall</td>
<td>4</td>
<td>2</td>
<td>Medium</td>
</tr>
<tr>
<td>EXO-03</td>
<td>Actuator failure</td>
<td>Motor burnout, control circuit failure</td>
<td>Loss of movement, entrapment</td>
<td>3</td>
<td>2</td>
<td>Low</td>
</tr>
<tr>
<td>EXO-04</td>
<td>Power loss</td>
<td>Battery depletion, connection failure</td>
<td>Device shutdown, potential fall</td>
<td>4</td>
<td>3</td>
<td>High</td>
</tr>
<tr>
<td>EXO-05</td>
<td>Range of motion excess</td>
<td>Software error, sensor failure</td>
<td>Joint injury, pain</td>
<td>4</td>
<td>2</td>
<td>Medium</td>
</tr>
<tr>
<td>EXO-06</td>
<td>Pinch point</td>
<td>Design flaw, improper use</td>
<td>Tissue entrapment, pain</td>
<td>3</td>
<td>3</td>
<td>Medium</td>
</tr>
<tr>
<td>EXO-07</td>
<td>Excessive force application</td>
<td>Control system error, sensor failure</td>
<td>Tissue damage, pain, fracture</td>
<td>4</td>
<td>2</td>
<td>Medium</td>
</tr>
<tr>
<td>EXO-08</td>
<td>Inadequate support</td>
<td>Design flaw, improper sizing</td>
<td>Instability, potential fall</td>
<td>3</td>
<td>3</td>
<td>Medium</td>
</tr>
<tr>
<td>EXO-09</td>
<td>Weight imbalance</td>
<td>Design flaw, improper adjustment</td>
<td>Instability, potential fall</td>
<td>3</td>
<td>3</td>
<td>Medium</td>
</tr>
<tr>
<td>EXO-10</td>
<td>Instability during use</td>
<td>Control algorithm error, sensor failure</td>
<td>Loss of balance, fall</td>
<td>4</td>
<td>4</td>
<td>Very High</td>
</tr>
<tr>
<td>EXO-11</td>
<td>Fastening system failure</td>
<td>Material fatigue, improper closure</td>
<td>Device detachment, potential fall</td>
<td>4</td>
<td>3</td>
<td>High</td>
</tr>
<tr>
<td>EXO-12</td>
<td>Sensor failure</td>
<td>Component failure, calibration error</td>
<td>Inaccurate movement control, potential injury</td>
<td>3</td>
<td>3</td>
<td>Medium</td>
</tr>
<tr>
<td>EXO-13</td>
<td>Battery overheating</td>
<td>Charging error, internal short</td>
<td>Burns, fire hazard</td>
<td>5</td>
<td>1</td>
<td>Medium</td>
</tr>
<tr>
<td>EXO-14</td>
<td>Frame structural failure</td>
<td>Material defect, excessive load</td>
<td>Collapse, potential injury</td>
<td>4</td>
<td>1</td>
<td>Low</td>
</tr>
<tr>
<td>EXO-15</td>
<td>Emergency stop failure</td>
<td>Component failure, design flaw</td>
<td>Inability to stop movement, potential injury</td>
<td>4</td>
<td>2</td>
<td>Medium</td>
</tr>
</table>

### 5.3 Software Subsystem Hazards and Risks

<table>
<tr>
<th>ID</th>
<th>Hazard</th>
<th>Cause</th>
<th>Harm</th>
<th>Severity</th>
<th>Probability</th>
<th>Risk Level</th>
</tr>
<tr>
<td>SW-01</td>
<td>Software crash</td>
<td>Programming error, memory leak</td>
<td>System shutdown, potential fall</td>
<td>4</td>
<td>3</td>
<td>High</td>
</tr>
<tr>
<td>SW-02</td>
<td>Algorithm error</td>
<td>Programming error, logic flaw</td>
<td>Erratic behavior, potential injury</td>
<td>4</td>
<td>3</td>
<td>High</td>
</tr>
<tr>
<td>SW-03</td>
<td>Data corruption</td>
<td>Memory error, power fluctuation</td>
<td>System malfunction, potential injury</td>
<td>4</td>
<td>2</td>
<td>Medium</td>
</tr>
<tr>
<td>SW-04</td>
<td>Calibration error</td>
<td>Algorithm limitation, data error</td>
<td>Inaccurate control, potential injury</td>
<td>3</td>
<td>3</td>
<td>Medium</td>
</tr>
<tr>
<td>SW-05</td>
<td>User interface confusion</td>
<td>Poor design, inadequate instructions</td>
<td>Improper use, potential injury</td>
<td>3</td>
<td>3</td>
<td>Medium</td>
</tr>
<tr>
<td>SW-06</td>
<td>Unauthorized access</td>
<td>Security vulnerability, intentional attack</td>
<td>Privacy breach, device manipulation</td>
<td>4</td>
<td>2</td>
<td>Medium</td>
</tr>
<tr>
<td>SW-07</td>
<td>Update failure</td>
<td>Connectivity issues, compatibility error</td>
<td>System malfunction, outdated safety features</td>
<td>3</td>
<td>2</td>
<td>Low</td>
</tr>
<tr>
<td>SW-08</td>
<td>Sensor data misinterpretation</td>
<td>Algorithm limitation, sensor noise</td>
<td>Incorrect movement, potential injury</td>
<td>4</td>
<td>3</td>
<td>High</td>
</tr>
<tr>
<td>SW-09</td>
<td>Communication failure</td>
<td>Protocol error, interference</td>
<td>System malfunction, potential injury</td>
<td>4</td>
<td>3</td>
<td>High</td>
</tr>
<tr>
<td>SW-10</td>
<td>Resource exhaustion</td>
<td>Memory leak, processing bottleneck</td>
<td>System slowdown or crash, potential injury</td>
<td>3</td>
<td>2</td>
<td>Low</td>
</tr>
<tr>
<td>SW-11</td>
<td>Timing error</td>
<td>Scheduling issue, interrupt handling</td>
<td>Delayed response, potential injury</td>
<td>3</td>
<td>3</td>
<td>Medium</td>
</tr>
<tr>
<td>SW-12</td>
<td>Configuration error</td>
<td>User error, data corruption</td>
<td>Improper operation, potential injury</td>
<td>3</td>
<td>3</td>
<td>Medium</td>
</tr>
<tr>
<td>SW-13</td>
<td>Malware infection</td>
<td>Security breach, unauthorized access</td>
<td>System compromise, potential injury</td>
<td>4</td>
<td>2</td>
<td>Medium</td>
</tr>
<tr>
<td>SW-14</td>
<td>Inadequate fail-safe mechanisms</td>
<td>Design oversight, implementation error</td>
<td>Failure to enter safe state, potential injury</td>
<td>5</td>
<td>3</td>
<td>Very High</td>
</tr>
<tr>
<td>SW-15</td>
<td>Machine learning drift</td>
<td>Data shift, algorithm limitation</td>
<td>Degraded performance, potential injury</td>
<td>3</td>
<td>3</td>
<td>Medium</td>
</tr>
</table>

### 5.4 Environmental Hazards and Risks

<table>
<tr>
<th>ID</th>
<th>Hazard</th>
<th>Cause</th>
<th>Harm</th>
<th>Severity</th>
<th>Probability</th>
<th>Risk Level</th>
</tr>
<tr>
<td>ENV-01</td>
<td>Electromagnetic interference</td>
<td>External equipment, power lines</td>
<td>Signal disruption, erratic behavior</td>
<td>4</td>
<td>3</td>
<td>High</td>
</tr>
<tr>
<td>ENV-02</td>
<td>Extreme temperature</td>
<td>Environmental conditions</td>
<td>Component failure, reduced performance</td>
<td>3</td>
<td>3</td>
<td>Medium</td>
</tr>
<tr>
<td>ENV-03</td>
<td>Moisture exposure</td>
<td>Rain, humidity, spills</td>
<td>Electrical short, component damage</td>
<td>4</td>
<td>3</td>
<td>High</td>
</tr>
<tr>
<td>ENV-04</td>
<td>Uneven surfaces</td>
<td>Stairs, ramps, rough terrain</td>
<td>Instability, fall</td>
<td>4</td>
<td>4</td>
<td>Very High</td>
</tr>
<tr>
<td>ENV-05</td>
<td>Confined spaces</td>
<td>Narrow doorways, crowded areas</td>
<td>Collision, entrapment</td>
<td>3</td>
<td>4</td>
<td>High</td>
</tr>
<tr>
<td>ENV-06</td>
<td>Obstacles</td>
<td>Furniture, cords, rugs</td>
<td>Trip, fall, collision</td>
<td>3</td>
<td>4</td>
<td>High</td>
</tr>
<tr>
<td>ENV-07</td>
<td>Slippery surfaces</td>
<td>Wet floors, ice, polished surfaces</td>
<td>Slip, fall</td>
<td>4</td>
<td>3</td>
<td>High</td>
</tr>
<tr>
<td>ENV-08</td>
<td>Dust exposure</td>
<td>Dusty environments</td>
<td>Component contamination, malfunction</td>
<td>3</td>
<td>3</td>
<td>Medium</td>
</tr>
<tr>
<td>ENV-09</td>
<td>Vibration exposure</td>
<td>Vehicle travel, machinery</td>
<td>Component loosening, malfunction</td>
<td>3</td>
<td>2</td>
<td>Low</td>
</tr>
<tr>
<td>ENV-10</td>
<td>Impact exposure</td>
<td>Dropping, collision</td>
<td>Component damage, malfunction</td>
<td>3</td>
<td>3</td>
<td>Medium</td>
</tr>
</table>

### 5.5 Use-Related Hazards and Risks

<table>
<tr>
<th>ID</th>
<th>Hazard</th>
<th>Cause</th>
<th>Harm</th>
<th>Severity</th>
<th>Probability</th>
<th>Risk Level</th>
</tr>
<tr>
<td>USE-01</td>
<td>Inadequate user training</td>
<td>Insufficient instruction, complexity</td>
<td>Improper use, potential injury</td>
<td>4</td>
<td>4</td>
<td>Very High</td>
</tr>
<tr>
<td>USE-02</td>
<td>Improper donning/doffing</td>
<td>Complexity, inadequate instruction</td>
<td>Improper fit, potential injury</td>
<td>3</td>
<td>4</td>
<td>High</td>
</tr>
<tr>
<td>USE-03</td>
<td>Exceeding operational limits</td>
<td>User error, inadequate warnings</td>
<td>Device damage, potential injury</td>
<td>3</td>
<td>3</td>
<td>Medium</td>
</tr>
<tr>
<td>USE-04</td>
<td>Improper maintenance</td>
<td>Inadequate instruction, user error</td>
<td>Reduced performance, potential failure</td>
<td>3</td>
<td>3</td>
<td>Medium</td>
</tr>
<tr>
<td>USE-05</td>
<td>Use by unauthorized person</td>
<td>Inadequate security, intentional misuse</td>
<td>Improper use, potential injury</td>
<td>3</td>
<td>2</td>
<td>Low</td>
</tr>
<tr>
<td>USE-06</td>
<td>Fatigue during use</td>
<td>Extended use, physical condition</td>
<td>Reduced control, potential fall</td>
<td>3</td>
<td>3</td>
<td>Medium</td>
</tr>
<tr>
<td>USE-07</td>
<td>Cognitive overload</td>
<td>Complex interface, multiple tasks</td>
<td>User error, potential injury</td>
<td>3</td>
<td>3</td>
<td>Medium</td>
</tr>
<tr>
<td>USE-08</td>
<td>Delayed emergency response</td>
<td>Isolation, communication failure</td>
<td>Prolonged exposure to hazard</td>
<td>4</td>
<td>3</td>
<td>High</td>
</tr>
<tr>
<td>USE-09</td>
<td>Improper charging</td>
<td>User error, inadequate instruction</td>
<td>Battery damage, potential fire</td>
<td>4</td>
<td>2</td>
<td>Medium</td>
</tr>
<tr>
<td>USE-10</td>
<td>Improper storage</td>
<td>User error, inadequate instruction</td>
<td>Component damage, reduced lifespan</td>
<td>2</td>
<td>3</td>
<td>Low</td>
</tr>
</table>

### 5.6 India-Specific Hazards and Risks

<table>
<tr>
<th>ID</th>
<th>Hazard</th>
<th>Cause</th>
<th>Harm</th>
<th>Severity</th>
<th>Probability</th>
<th>Risk Level</th>
</tr>
<tr>
<td>INDIA-01</td>
<td>Power outage during use</td>
<td>Unreliable power grid in some regions</td>
<td>Device shutdown, potential fall</td>
<td>4</td>
<td>4</td>
<td>Very High</td>
</tr>
<tr>
<td>INDIA-02</td>
<td>Voltage fluctuation</td>
<td>Unstable power supply in some regions</td>
<td>Component damage, potential injury</td>
<td>4</td>
<td>4</td>
<td>Very High</td>
</tr>
<tr>
<td>INDIA-03</td>
<td>Inadequate grounding</td>
<td>Improper electrical grounding in homes</td>
<td>Electrical shock, component damage</td>
<td>4</td>
<td>3</td>
<td>High</td>
</tr>
<tr>
<td>INDIA-04</td>
<td>Limited internet connectivity</td>
<td>Inability to access remote monitoring/support</td>
<td>Delayed intervention, potential injury</td>
<td>3</td>
<td>4</td>
<td>High</td>
</tr>
<tr>
<td>INDIA-05</td>
<td>Monsoon flooding</td>
<td>Water exposure during seasonal flooding</td>
<td>Electrical hazards, component failure</td>
<td>4</td>
<td>3</td>
<td>High</td>
</tr>
<tr>
<td>INDIA-06</td>
<td>Extreme heat conditions</td>
<td>Operation in temperatures exceeding specifications</td>
<td>Overheating, component failure</td>
<td>3</td>
<td>4</td>
<td>High</td>
</tr>
<tr>
<td>INDIA-07</td>
<td>High dust environments</td>
<td>Dust ingress into sensitive components</td>
<td>Component failure, potential injury</td>
<td>3</td>
<td>4</td>
<td>High</td>
</tr>
<tr>
<td>INDIA-08</td>
<td>Limited access to service centers</td>
<td>Delayed maintenance or repair</td>
<td>Continued use of faulty device, injury</td>
<td>3</td>
<td>3</td>
<td>Medium</td>
</tr>
<tr>
<td>INDIA-09</td>
<td>Uneven road/pathway surfaces</td>
<td>Operation on broken pavements or unpaved areas</td>
<td>Fall, impact injuries</td>
<td>4</td>
<td>4</td>
<td>Very High</td>
</tr>
<tr>
<td>INDIA-10</td>
<td>Limited emergency medical services</td>
<td>Delayed emergency response in rural areas</td>
<td>Worsening of injury condition</td>
<td>4</td>
<td>3</td>
<td>High</td>
</tr>
<tr>
<td>INDIA-11</td>
<td>Incompatible electrical outlets</td>
<td>Use of adapters or improper connections</td>
<td>Electrical hazards, component damage</td>
<td>3</td>
<td>3</td>
<td>Medium</td>
</tr>
<tr>
<td>INDIA-12</td>
<td>Language and literacy barriers</td>
<td>Inability to understand instructions or warnings</td>
<td>Improper use, potential injury</td>
<td>3</td>
<td>4</td>
<td>High</td>
</tr>
<tr>
<td>INDIA-13</td>
<td>Shared living spaces</td>
<td>Limited space for safe operation in multi-family homes</td>
<td>Collision, fall, injury to others</td>
<td>3</td>
<td>3</td>
<td>Medium</td>
</tr>
<tr>
<td>INDIA-14</td>
<td>Electromagnetic interference from unregulated devices</td>
<td>Signal disruption from nearby electronics</td>
<td>Erratic behavior, potential injury</td>
<td>3</td>
<td>3</td>
<td>Medium</td>
</tr>
<tr>
<td>INDIA-15</td>
<td>Limited availability of replacement parts</td>
<td>Extended downtime during repairs</td>
<td>Prolonged mobility limitation</td>
<td>2</td>
<td>3</td>
<td>Low</td>
</tr>
<tr>
<td>INDIA-16</td>
<td>Unauthorized repair attempts</td>
<td>Limited access to authorized service centers</td>
<td>Device malfunction, potential injury</td>
<td>4</td>
<td>3</td>
<td>High</td>
</tr>
<tr>
<td>INDIA-17</td>
<td>Inadequate home accessibility</td>
<td>Traditional home designs with steps/thresholds</td>
<td>Falls, restricted mobility</td>
<td>3</td>
<td>4</td>
<td>High</td>
</tr>
<tr>
<td>INDIA-18</td>
<td>Extended power outages</td>
<td>Infrastructure limitations in some regions</td>
<td>Battery depletion, mobility loss</td>
<td>3</td>
<td>3</td>
<td>Medium</td>
</tr>
<tr>
<td>INDIA-19</td>
<td>Exposure to religious/cultural gatherings</td>
<td>Crowded environments with varied surfaces</td>
<td>Falls, collisions, device damage</td>
<td>3</td>
<td>3</td>
<td>Medium</td>
</tr>
<tr>
<td>INDIA-20</td>
<td>Exposure to seasonal conditions (monsoon)</td>
<td>High humidity, water exposure</td>
<td>Component failure, electrical hazards</td>
<td>4</td>
<td>3</td>
<td>High</td>
</tr>
</table>

### 5.7 US-Specific Hazards and Risks

<table>
<tr>
<th>ID</th>
<th>Hazard</th>
<th>Cause</th>
<th>Harm</th>
<th>Severity</th>
<th>Probability</th>
<th>Risk Level</th>
</tr>
<tr>
<td>US-01</td>
<td>Incompatibility with US power supply</td>
<td>Voltage/frequency differences (120V/60Hz)</td>
<td>Component damage, potential injury</td>
<td>3</td>
<td>2</td>
<td>Low</td>
</tr>
<tr>
<td>US-02</td>
<td>Electromagnetic interference from medical equipment</td>
<td>Hospital/clinic environment</td>
<td>Signal disruption, erratic behavior</td>
<td>4</td>
<td>3</td>
<td>High</td>
</tr>
<tr>
<td>US-03</td>
<td>Incompatibility with US telecommunications</td>
<td>Different cellular networks/frequencies</td>
<td>Remote monitoring failure</td>
<td>3</td>
<td>2</td>
<td>Low</td>
</tr>
<tr>
<td>US-04</td>
<td>ADA compliance issues</td>
<td>Incompatibility with accessibility standards</td>
<td>Restricted access, potential injury</td>
<td>3</td>
<td>3</td>
<td>Medium</td>
</tr>
<tr>
<td>US-05</td>
<td>Extreme weather conditions</td>
<td>Snow, ice, extreme cold in northern regions</td>
<td>Component failure, reduced performance</td>
<td>3</td>
<td>3</td>
<td>Medium</td>
</tr>
<tr>
<td>US-06</td>
<td>Incompatibility with US healthcare IT systems</td>
<td>Different data standards/protocols</td>
<td>Data integration failure</td>
<td>2</td>
<td>3</td>
<td>Low</td>
</tr>
<tr>
<td>US-07</td>
<td>Liability concerns affecting usage</td>
<td>US litigation environment</td>
<td>Restricted use, reduced benefit</td>
<td>2</td>
<td>3</td>
<td>Low</td>
</tr>
<tr>
<td>US-08</td>
<td>Insurance reimbursement issues</td>
<td>Coverage limitations</td>
<td>Limited access to device</td>
<td>2</td>
<td>4</td>
<td>Medium</td>
</tr>
<tr>
<td>US-09</td>
<td>Home healthcare provider integration issues</td>
<td>Training limitations, protocol differences</td>
<td>Inadequate support, potential injury</td>
<td>3</td>
<td>3</td>
<td>Medium</td>
</tr>
<tr>
<td>US-10</td>
<td>Incompatibility with US emergency response systems</td>
<td>Different emergency protocols</td>
<td>Delayed emergency response</td>
<td>4</td>
<td>2</td>
<td>Medium</td>
</tr>
</table>

## üìä Risk Analysis Results

### 6.1 Risk Distribution by Category

The following chart shows the distribution of risks by category:

![Risk Distribution by Category](https://mermaid.ink/img/pako:eNqNkk1uwzAMhV-F0KqF4xfoIk3qBEWBLlJ00Y3BS7QRYlOuJKdoEOTdS9tJ4_6gy4j8-PhIyoVxKwkKeEHekmF8aMM9khVRfELy0VkkT9aRVhFd0DokZC9WRZSEvEZFZAypCFdklXekI1zEeZzHWZzH_2Ln-6gjXMZ5nMd5nMf5v9hFhFdxHudxHudxHucxdn6OOsJ1nMd5nMd5nMd5jJ3foo7wLs7jPM7jPM7jPMbOH1FH-BjncR7ncR7ncR5j50_UEX7FeZzHeZzHeZzH2HkXdYQ_cR7ncR7ncR7nMXb-jTrCY5zHeZzHeZzHeYyd06gjPMV5nMd5nMd5nMfYOYvwFOdxHudxHudxHmPnPMJTnMd5nMd5nMd5jJ2LCE9xHudxHudxHucxdi4jPMd5nMd5nMd5nMfYuYrwHOdxHudxHudxHmPnOsJLnMd5nMd5nMd5jJ2bCC9xHudxHudxHucxdm4jvMR5nMd5nMd5nMfYuYvwEudxHudxHudxHmPnPsJrnMd5nMd5nMd5jJ3HCK9xHudxHudxHucxdp4ivMV5nMd5nMd5nMfYeY7wFudxHudxHudxHmPnJcJbnMd5nMd5nMd5jJ3XCG9xHudxHudxHucxdt4ivMd5nMd5nMd5nMfYeY_wHudxHudxHudxHmPnI8J7nMd5nMd5nMd5jJ2vCB9xHudxHudxHucxdr4jfMR5nMd5nMd5nMfY-YnwEedxHudxHudxHmPnvwgfcR7ncR7ncR7nMXb-B8b18Ck?type=png)

### 6.2 Risk Level Distribution

| Risk Level | Count | Percentage |
|------------|-------|------------|
| Very High | 8 | 7% |
| High | 24 | 22% |
| Medium | 45 | 41% |
| Low | 33 | 30% |
| **Total** | **110** | **100%** |

### 6.3 Critical Risk Items

The following items have been identified as Very High initial risk and require immediate attention for risk control implementation:

1. **BCI-11: Signal misclassification** - Incorrect interpretation of user intent leading to unintended movement
2. **EXO-10: Instability during use** - Loss of balance during movement leading to falls
3. **SW-14: Inadequate fail-safe mechanisms** - Failure to enter safe state when problems detected
4. **ENV-04: Uneven surfaces** - Operation on stairs, ramps, or uneven ground leading to falls
5. **USE-01: Inadequate user training** - Improper use due to insufficient training
6. **INDIA-01: Power outage during use** - Device shutdown due to unreliable power grid in some regions
7. **INDIA-02: Voltage fluctuation** - Component damage due to unstable power supply in some regions
8. **INDIA-09: Uneven road/pathway surfaces** - Falls due to operation on broken pavements or unpaved areas

## üîç Market-Specific Risk Analysis

### 7.1 United States Market Risk Analysis

#### 7.1.1 FDA-Specific Risk Considerations

1. **Benefit-Risk Analysis Context**:
   - FDA's benefit-risk framework emphasizes patient-centric approaches
   - Consideration of patient perspectives in risk evaluation
   - Emphasis on "least burdensome approach" while maintaining safety and effectiveness
   - Documentation of benefit-risk determinations for regulatory submissions

2. **Human Factors Considerations**:
   - Emphasis on use-related risk analysis following FDA guidance
   - Consideration of use environments typical in US healthcare settings
   - Analysis of risks associated with home use in US context
   - Documentation requirements for human factors engineering

3. **Software as a Medical Device (SaMD) Considerations**:
   - Classification according to FDA SaMD framework
   - Consideration of FDA's pre-cert program principles
   - Analysis of cybersecurity risks according to FDA guidance
   - Documentation requirements for software validation

4. **Post-Market Risk Monitoring**:
   - Alignment with FDA's Real-World Evidence program
   - Consideration of FDA Adverse Event Reporting System requirements
   - Analysis of risks related to product modifications and updates
   - Documentation requirements for post-market surveillance

#### 7.1.2 US Healthcare System Integration Risks

1. **Healthcare Provider Interaction Risks**:
   - Training requirements for US healthcare providers
   - Integration with US clinical workflows
   - Compatibility with US healthcare IT systems
   - Reimbursement and insurance considerations

2. **US Home Healthcare Considerations**:
   - Integration with US home healthcare services
   - Compatibility with US telehealth platforms
   - Alignment with US home health agency protocols
   - Consideration of caregiver availability and training

3. **US Emergency Response Integration**:
   - Compatibility with US emergency response systems
   - Integration with 911 services
   - Alignment with US emergency medical service protocols
   - Consideration of emergency response times in different regions

### 7.2 Indian Market Risk Analysis

#### 7.2.1 CDSCO-Specific Risk Considerations

1. **Infrastructure Challenges**:
   - Power reliability and quality variations across regions
   - Internet connectivity limitations affecting remote monitoring
   - Emergency service accessibility variations
   - Transportation infrastructure affecting service access
   - Regional variations in healthcare infrastructure

2. **Environmental Factors**:
   - Monsoon season impacts on device operation
   - Extreme temperature conditions in various regions
   - High dust environments in many areas
   - Humidity variations across regions and seasons
   - Regional climate variations affecting device performance

3. **Home Use Considerations**:
   - Traditional home designs with accessibility challenges
   - Shared living spaces with limited privacy
   - Varied flooring surfaces and conditions
   - Limited space for device operation and storage
   - Family-centered care model implications

4. **Cultural and Regional Factors**:
   - Language diversity affecting instruction comprehension
   - Literacy level variations affecting written instructions
   - Cultural practices affecting device usage patterns
   - Religious gatherings and festivals creating unique use environments
   - Regional variations in technology adoption

5. **Healthcare System Integration**:
   - Limited specialist availability in many regions
   - Varied healthcare infrastructure quality
   - Telemedicine adoption variations
   - Family-centered care model implications
   - Regional variations in healthcare access

#### 7.2.2 Make in India Considerations

1. **Local Manufacturing Risks**:
   - Component availability and quality
   - Manufacturing process variations
   - Quality control challenges
   - Supply chain reliability
   - Workforce training and expertise

2. **Local Supply Chain Risks**:
   - Supplier quality management
   - Component traceability
   - Logistics and transportation challenges
   - Inventory management in varied conditions
   - Regional variations in supply chain reliability

3. **Service and Support Risks**:
   - Regional service center availability
   - Technician training and expertise
   - Spare parts availability and distribution
   - Service response time variations
   - Regional variations in service quality

## üìù Risk Analysis Conclusions

### 8.1 Key Findings

1. **Critical Areas of Concern**:
   - Signal classification accuracy and reliability
   - Physical stability during operation
   - Fail-safe mechanisms
   - User training and supervision
   - Environmental interactions
   - Power reliability and quality in India
   - Uneven surfaces in Indian environments
   - Language and literacy barriers in India

2. **Common Failure Modes**:
   - Signal processing errors
   - Mechanical failures
   - Software malfunctions
   - User errors
   - Environmental challenges
   - Infrastructure limitations in India
   - Power-related issues in India

3. **Highest Severity Potential Harms**:
   - Falls resulting in serious injury
   - Unintended movements causing joint injury
   - Entrapment in emergency situations
   - Electrical hazards
   - Cybersecurity breaches affecting device control
   - Delayed emergency response in rural Indian areas

### 8.2 Integrated Risk Analysis Conclusions

This unified risk analysis has identified 110 potential hazards associated with the Chimera neural interface system across both US and Indian markets. The analysis reveals that 29% of identified risks are initially categorized as High or Very High, indicating the need for comprehensive risk control measures before the device can be considered safe for use.

The most critical risk areas requiring attention are:

1. **Core Technology Risks**:
   - BCI signal classification accuracy and reliability
   - Physical stability and fall prevention
   - Software fail-safe mechanisms

2. **User Interaction Risks**:
   - User training and supervision requirements
   - Interface design and feedback mechanisms
   - Language and literacy considerations

3. **Environmental Risks**:
   - Operation on uneven surfaces
   - Environmental condition variations
   - Infrastructure limitations

4. **India-Specific Risks**:
   - Power reliability and quality
   - Environmental conditions (heat, dust, monsoon)
   - Home environment challenges
   - Emergency response limitations

### 8.3 Recommendations for Risk Control

Based on this analysis, the following risk control priorities are recommended:

1. **Design Controls**:
   - Implement redundant signal validation algorithms
   - Enhance mechanical stability features
   - Develop comprehensive fail-safe mechanisms
   - Improve user interface clarity and feedback
   - Design for power quality variations in India
   - Enhance dust and moisture resistance for Indian conditions

2. **Protective Measures**:
   - Implement physical fall prevention mechanisms
   - Add redundant emergency stop capabilities
   - Incorporate automatic hazard detection systems
   - Develop robust error detection and handling
   - Implement backup power systems for Indian market
   - Design for offline operation during connectivity issues

3. **Information for Safety**:
   - Develop comprehensive training programs
   - Create clear user instructions and warnings
   - Establish detailed supervision requirements
   - Provide environmental assessment guidelines
   - Develop multilingual instructions for Indian market
   - Create visual/pictorial guides for varied literacy levels

## üåü Billion-Dollar Funding Considerations

### 9.1 Risk Analysis Strengths for Investors

This Unified Risk Analysis supports billion-dollar funding objectives through:

1. **Comprehensive Risk Identification**:
   - Systematic identification of 110 potential hazards
   - Consideration of both general and market-specific risks
   - Analysis of risks across the entire product lifecycle
   - Identification of risks in all use environments

2. **Rigorous Risk Assessment Methodology**:
   - Use of multiple complementary risk analysis methods
   - Structured severity and probability estimation
   - Clear risk acceptability criteria
   - Transparent risk evaluation process

3. **Market-Specific Risk Understanding**:
   - Detailed analysis of US market risks
   - Comprehensive analysis of Indian market risks
   - Consideration of regulatory requirements in both markets
   - Understanding of infrastructure and environmental variations

4. **Strategic Risk Prioritization**:
   - Clear identification of critical risk items
   - Prioritization of risks for control implementation
   - Focus on high-impact risk areas
   - Balanced consideration of all risk categories

### 9.2 Competitive Advantage Demonstration

1. **Superior Risk Management Approach**:
   - More comprehensive than industry standard approaches
   - Integration of multiple regulatory frameworks
   - Consideration of market-specific factors
   - Use of advanced risk analysis methods

2. **Market Expansion Readiness**:
   - Understanding of risks in multiple markets
   - Preparation for simultaneous regulatory submissions
   - Consideration of diverse user populations
   - Adaptation to varied infrastructure and environments

3. **Liability Mitigation Strategy**:
   - Thorough documentation of risk analysis process
   - Clear rationale for risk acceptability decisions
   - Comprehensive consideration of foreseeable risks
   - Preparation for regulatory scrutiny

4. **Innovation with Safety Focus**:
   - Balance of innovative technology with safety considerations
   - Identification of technology-specific risks
   - Consideration of novel use environments
   - Preparation for safe market introduction

## üìö Related Documents

- [Unified Risk Management Plan](/regulatory/risk_management/unified_risk_management_plan.md)
- [FDA Risk Analysis](/regulatory/risk_management/fda_risk_analysis.md)
- [Indian Risk Analysis](/regulatory/risk_management/indian_risk_analysis.md)
- [Unified Risk Controls](/regulatory/risk_management/unified_risk_controls.md)
- [FDA Risk Controls](/regulatory/risk_management/fda_risk_controls.md)
- [Indian Risk Controls](/regulatory/risk_management/indian_risk_controls.md)

## üìú References

1. ISO 14971:2019 - Medical devices ‚Äî Application of risk management to medical devices
2. ISO/TR 24971:2020 - Medical devices ‚Äî Guidance on the application of ISO 14971
3. FDA Guidance - Factors to Consider Regarding Benefit-Risk in Medical Device Product Availability, Compliance, and Enforcement Decisions
4. FDA Guidance - Applying Human Factors and Usability Engineering to Medical Devices
5. FDA Guidance - Content of Premarket Submissions for Management of Cybersecurity in Medical Devices
6. CDSCO Medical Device Rules, 2017 (as amended)
7. CDSCO Guidelines for Software as Medical Device (SaMD)
8. Digital Personal Data Protection Act, 2023 (India)
9. IEC 62304:2015 - Medical device software ‚Äî Software life cycle processes
10. IEC 62366-1:2015 - Medical devices ‚Äî Application of usability engineering to medical devices
11. IMDRF SaMD: Risk Categorization Framework
12. NIST Cybersecurity Framework

## üîÑ Approval and Review

### 10.1 Approval

This Unified Risk Analysis has been reviewed and approved by:

| Name | Role | Signature | Date |
|------|------|-----------|------|
| [Name] | Chief Executive Officer | [Signature] | April 17, 2025 |
| [Name] | Chief Technology Officer | [Signature] | April 17, 2025 |
| [Name] | Clinical Director | [Signature] | April 17, 2025 |
| [Name] | Quality Assurance Director | [Signature] | April 17, 2025 |
| [Name] | Regulatory Affairs Director | [Signature] | April 17, 2025 |
| [Name] | Risk Management Director | [Signature] | April 17, 2025 |
| [Name] | India Market Specialist | [Signature] | April 17, 2025 |

### 10.2 Review Schedule

This Unified Risk Analysis shall be reviewed:

- When significant changes are made to the device or its intended use
- When new hazards or risks are identified
- When regulatory requirements change
- When post-market information indicates the need for updates
- At least annually as part of the risk management review process

---

<div align="center">
<p><strong>Chimera Neurotechnology</strong><br>
Bengaluru, Karnataka, India & San Francisco, California, USA<br>
Document No: RM-ANALYSIS-UNIFIED-001 | Version: 2.0 | April 17, 2025</p>
</div>
